Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY)

Future Virology, Ahead of Print.

Source: Future Virology - November 1, 2023 Category: Virology Authors: Arantxa Horga Rebecca Saenz G ürdal Yilmaz Abraham Sim ón-Campos Keith Pietropaolo William J Stubbings Neil Collinson Laura Ishak Barbara Zrinscak Bruce Belanger Catherine Granier Kai Lin Aeron C  Hurt Xiao-Jian Zhou Steffen Wildum Janet Hammond Source Type: research